600216.SH
浙江医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.55
−5.14%Next report
Analyst consensus
- Next report date
- Oct 22, 2026
- EPS estimate
- CNY 0.28
- Revenue estimate
- CNY 2.2B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- CNY 0.25
- EPS estimate
- CNY 0.25
- Revenue actual
- CNY 2.2B
- Revenue estimate
- CNY 2.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 22, 2026